N C Dlova1, S H Hamed2, J Tsoka-Gwegweni3, A Grobler4. 1. Dermatology Department, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Congella 4013, Durban, South Africa. 2. Faculty of Pharmaceutical Sciences, Hashemite University, Zarqa, Jordan. 3. Department of Public Health Medicine, School of Nursing and Public Health, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa. 4. Centre for the AIDS Programme of Research in South Africa (CAPRISA), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Congella 4013, Durban, South Africa.
Abstract
BACKGROUND: Cutaneous adverse sequelae of skin lightening creams present with myriad skin complications and affect dermatology practice, particularly in sub-Saharan Africa where such products are widely used, with a prevalence of 25-67%. OBJECTIVES: To examine the skin lightening practices of both African and Indian women living in South Africa. METHODS: A cross-sectional survey was undertaken in the general outpatient departments of two regional university hospitals in Durban, South Africa. All consenting African and Indian women aged 18-70 years were recruited and asked to complete a questionnaire. RESULTS: Six hundred women completed the questionnaire, of whom 32·7% reported using skin lightening products. The main reasons cited were treatment of skin problems (66·7%) and skin lightening (33·3%). Products were purchased from a variety of sources. Twenty-five percent reported using sunscreen. CONCLUSIONS: The use of skin lightening cosmetics is common among darkly pigmented South African women, including those of both African and Indian ancestries. Despite more than 20 years of governmental regulations aimed at prohibiting both the sale of cosmetics containing mercury, hydroquinone and corticosteroids, and the advertising of any kind of skin lightener, they are far from having disappeared. The main motivations for using these products are the desire to treat skin disorders and to achieve a lighter skin colour. Television and magazine advertisements seem to influence women's choice of these products and, thus, would be efficient channels for raising public awareness about the dangers of using uncontrolled skin lighteners.
BACKGROUND: Cutaneous adverse sequelae of skin lightening creams present with myriad skin complications and affect dermatology practice, particularly in sub-Saharan Africa where such products are widely used, with a prevalence of 25-67%. OBJECTIVES: To examine the skin lightening practices of both African and Indian women living in South Africa. METHODS: A cross-sectional survey was undertaken in the general outpatient departments of two regional university hospitals in Durban, South Africa. All consenting African and Indian women aged 18-70 years were recruited and asked to complete a questionnaire. RESULTS: Six hundred women completed the questionnaire, of whom 32·7% reported using skin lightening products. The main reasons cited were treatment of skin problems (66·7%) and skin lightening (33·3%). Products were purchased from a variety of sources. Twenty-five percent reported using sunscreen. CONCLUSIONS: The use of skin lightening cosmetics is common among darkly pigmented South African women, including those of both African and Indian ancestries. Despite more than 20 years of governmental regulations aimed at prohibiting both the sale of cosmetics containing mercury, hydroquinone and corticosteroids, and the advertising of any kind of skin lightener, they are far from having disappeared. The main motivations for using these products are the desire to treat skin disorders and to achieve a lighter skin colour. Television and magazine advertisements seem to influence women's choice of these products and, thus, would be efficient channels for raising public awareness about the dangers of using uncontrolled skin lighteners.
Authors: Louise A Brinton; Jonine D Figueroa; Daniel Ansong; Kofi M Nyarko; Seth Wiafe; Joel Yarney; Richard Biritwum; Michelle Brotzman; Jake E Thistle; Ernest Adjei; Francis Aitpillah; Florence Dedey; Lawrence Edusei; Nicholas Titiloye; Baffour Awuah; Joe Nat Clegg-Lamptey; Beatrice Wiafe-Addai; Verna Vanderpuye Journal: Carcinogenesis Date: 2018-04-05 Impact factor: 4.944
Authors: Louise A Brinton; Baffour Awuah; Joe Nat Clegg-Lamptey; Beatrice Wiafe-Addai; Daniel Ansong; Kofi M Nyarko; Seth Wiafe; Joel Yarney; Richard Biritwum; Michelle Brotzman; Andrew A Adjei; Ernest Adjei; Francis Aitpillah; Lawrence Edusei; Florence Dedey; Sarah J Nyante; Joseph Oppong; Ernest Osei-Bonsu; Nicholas Titiloye; Verna Vanderpuye; Emma Brew Abaidoo; Bernard Arhin; Isaac Boakye; Margaret Frempong; Naomi Ohene Oti; Victoria Okyne; Jonine D Figueroa Journal: Int J Cancer Date: 2017-03-28 Impact factor: 7.396
Authors: Louise A Brinton; Britton Trabert; Ashley M Geczik; Roni T Falk; Xia Xu; Beatrice Wiafe-Addai; Joel Yarney; Baffour Awuah; Richard Biritwum; Verna Vanderpuye; Florence Dedey; Ernest Adjei; Francis Aitpillah; Ernest Osei-Bonsu; Joseph Oppong; Nicholas Titiloye; Lawrence Edusei; Kofi Nyarko; Joe-Nat Clegg-Lamptey; Seth Wiafe; Daniel Ansong; Thomas U Ahearn; Jonine Figueroa; Montserrat Garcia-Closas Journal: J Expo Sci Environ Epidemiol Date: 2022-01-06 Impact factor: 6.371
Authors: Dana S Saade; Mayra B C Maymone; Henriette De La Garza; Eric A Secemsky; Kevin F Kennedy; Neelam A Vashi Journal: Int J Environ Res Public Health Date: 2021-05-25 Impact factor: 3.390
Authors: Collin A Eagles-Smith; Ellen K Silbergeld; Niladri Basu; Paco Bustamante; Fernando Diaz-Barriga; William A Hopkins; Karen A Kidd; Jennifer F Nyland Journal: Ambio Date: 2018-03 Impact factor: 5.129